Sunlenca Product Label
Interaction Color Code
Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 1 dose
600 mg BID x 2 days, then 600 mg daily x 1
Drug 1 effect
Not reported
Drug 2
Drug 2 dose
2.5 mg orally x 1, administered simultaneously with LEN
Drug 2 effect
AUC increased 259%; Cmax increased 94%. AUC for 1-hydroxy metabolite decreased 24%.
Clinical Effects
Potential for increased sedation
Management
If co-administering, monitor for excess sedation and adjust dose accordingly
Info Source
